Benign monoclonal gammopathy: a reassessment of the problem
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 14 (3) , 183-197
- https://doi.org/10.3109/08820138509076143
Abstract
Disease associations of clonally restricted serum immunoglobulin (Ig) abnormalities were examined using methods for detecting and characterizing homogeneous Ig that are approximately forty times more sensitive than either cellulose acetate zone electrophoresis or immunoelectrophoresis. Medical records of three hundred five patients with clonally-restricted serum immunoglobulins, including 100 monoclonal gammopathies, and 205 immune complex/oligoclonal patterns were reviewed to obtain the attending physician's discharge diagnosis. Our data confirm lymphoproliferative disorders as the most frequent cause of monoclonal gammopathy (63% of our cases). However, in contrast to earlier reports, we found little evidence to support an association between monoclonal gammopathy and non-reticular malignancy. This does not mean our patients with these disorders had normal serum immunoglobulin patterns; rather, their qualitative abnormalities were, for the most part, not monoclonal. Instead, patients with these diseases had a high incidence of serum immune complexes and their antibody excess sequelae, oligoclonal patterns, Oligoclonal responses are noteworthy because Ig products of the individual clones do not always achieve equivalent serum concentrations, nor are the various clonal products synchronized with respect to the time at which they attain peak concentration, This creates a number of problems For laboratories attempting to characterize such abnormalities; 1) some analytical methods may only be capable of detecting the dominant clone of an oligoclonal pattern, and 2) analysis of a single specimen may yield erroneous results because the unique waxing and waning kinetic pattern of oligoclonal responses may preclude identification of all components at a single time point. We conclude that benign “monoclonal” gamnopathies and circulating immune complex/oligoclonal Ig abnormalities occur in the same clinical situations and may be synonymous. The sensitivity of an individual laboratory's analytical methods would then determine which name is applied.This publication has 19 references indexed in Scilit:
- Microheterogeneity of serum myeloma immunoglobulins revealed by a technique of high resolution two‐dimensional electrophoresisElectrophoresis, 1980
- Monoclonal immunoglobulin disorders: a report of 154 casesThe Lancet Healthy Longevity, 1976
- The Frequency of M-components in Sera of Patients with Solid Malignant NeoplasmsBritish Journal of Cancer, 1973
- M-ComponentsPublished by American Medical Association (AMA) ,1973
- PATHOLOGIC CONDITIONS ASSOCIATED WITH PLASMA CELL DYSCRASIAS: A STUDY OF 806 CASES *Annals of the New York Academy of Sciences, 1971
- Studies of “Benign” Serum M-ComponentsThe Lancet Healthy Longevity, 1969
- Monoclonal gammopathy in human neoplasiaCancer, 1968
- Streptococcal group-specific antibodies: occurrence of a restricted population following secondary immunization.Proceedings of the National Academy of Sciences, 1968
- Paraproteins, benign or malignant?BMJ, 1967
- Development of Plasma-Cell Neoplasms in BALB/c Mice After Intraperitoneal Injection of Paraffin-Oil Adjuvant, Heat-Killed Staphylococcus MixturesJNCI Journal of the National Cancer Institute, 1960